NCT04076917View on ClinicalTrials.gov

Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection

TerminatedOBSERVATIONAL

Enrollment

84

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions

Atrial Fibrillation

Trial Locations (5)

32792

Florida Cardiology, Winter Park

34741

Cardiovascular Associates, Inc., Kissimmee

43210

The Ohio State University, Columbus

43615

ProMedica Physicians Cardiology, Toledo

63136

St. Louis Heart and Vascular, St Louis

Sponsors

Lead Sponsor

Biotronik, Inc.

All Listed Sponsors

lead

Biotronik, Inc.

INDUSTRY